OligoNova Hub is Sweden's new national infrastructure for drug development, especially focused on therapeutic oligonucleotides. Here, researchers with expertise in e.g. bioinformatics, chemistry and cellular biology will work with innovative development projects of drugs for patient groups that currently lack appropriate treatment.
OligoNova Hub is one of four parts in a broader OligoNova organisation. In addition to the hub, there are also OligoNova Accelerate, Challenges and Network. Together, all four parts will contribute to innovative solutions, new drug patents, start-up companies and effective treatment for patients.